Growth Drivers
Growing Prevalence of Genetic Diseases and Disorders – stem cells are used to repair tissues that are affected or damaged by the genetic mutation. Adult stem cells are highly utilized to cure genetic diseases and disorders. Common types of genetic diseases are Huntington’s, Cystic Fibrosis & Liver disease, and Sickle disease while types of genetic disorders are down syndrome, turner syndrome, Klinefelter syndrome, and others. The higher prevalence of these diseases is expected to hike the market growth over the forecast period. For instance, it was observed that in every 10 people, 6 of them suffer from a condition with genetic background.
Rising Geriatric Population – Elderly population is more prone to get diseases and disorders and the boom in elderly populations worldwide is anticipated to drive market growth during the forecast period. More than 60% of people across the globe will double from 12 to 22% between 2015 and 2050. Meanwhile, as of 2020, there were more people over the age of 60, and it is further expected that approximately 80% of the global geriatric population will dwell in low- and middle-income countries.
Increasing Instances of Cardiovascular Diseases – stem cell therapy is not helpful for all patients of cardiovascular disease but with lifestyle modification, it can be quite a safe and effective alternative treatment. Additionally, stem cells are noticed to be a non-surgical medium to repair damaged heart muscle. For instance, approximately 350,000 people lost their lives on account of coronary heart disease in 2020 across the globe.
Growing Cases of Parkinson’s Disease – it has been observed that mesenchymal stem cell therapy can repair the damaged brain cells by Parkinson’s disease but there is no medical proof that it can completely cure the disease. These cells are used to treat motor symptoms of Parkinson’s disease. For instance, it was estimated that around 88,000 new cases of Parkinson’s disease are diagnosed in the United States every year.
Rising Demand for Stem Cell Treatment in Type 1 Diabetes- there are several documented cases of type 1 diabetes where patients lived for years without needing insulin injections when using cord blood stem cells. For instance, approximately 8 million people across the globe were anticipated to have type 1 diabetes in 2021.
Challenges
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
14.4% |
Base Year Market Size (2024) |
USD 3.93 billion |
Forecast Year Market Size (2037 |
USD 22.59 billion |
Regional Scope |
|
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?